Stay updated on CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial

Sign up to get notified when there's something new on the CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page shows a new revision tag (v3.6.6) replacing the previous v3.6.5, indicating a systems update to the page template rather than a change to study data.
    Difference
    0.0%
    Check dated 2026-08-31T23:01:17.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page revision number was updated from v3.6.4 to v3.6.5, indicating a small update to the study record.
    Difference
    0.0%
    Check dated 2026-08-10T12:32:33.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.3 to v3.6.4, reflecting a minor update to the page system. No study content or results were changed.
    Difference
    0.0%
    Check dated 2026-07-27T06:19:05.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, replacing the previous v3.6.2. This reflects a new version of the page metadata rather than a substantive change to the information shown.
    Difference
    0.0%
    Check dated 2026-07-05T10:49:07.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Page metadata was updated from Revision v3.6.0 to v3.6.2, indicating a minor patch release of the page system. This update does not introduce changes to the study text or data.
    Difference
    0.0%
    Check dated 2026-06-28T06:38:49.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Recruitment status on the study page now shows 'No longer looking for participants', signaling that enrollment is closed. The page also adds new help/navigation items ('How to Read a Study Record', 'Common Questions', 'How to Join a Study'), updates the Intervention/Treatment heading formatting, and includes a revision note 'Revision: v3.6.0'.
    Difference
    0.2%
    Check dated 2026-06-14T05:24:53.000Z thumbnail image

Stay in the know with updates to CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CB-839 Combo vs. Cabozantinib in Metastatic RCC Clinical Trial page.